LeslieMRandallMD, MAS, FACS
Obstetrics & Gynecology • Richmond, VAGynecologic Oncology
Professor and Director Division of Gynecologic Oncology
Dr. Randall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1250 E Marshall St
Richmond, VA 23298Phone+1 804-828-7738
Summary
- Board-certified Gynecologist and Gynecologic Oncologist, specializing in advanced pelvic and cytoreductive surgery, investigational chemotherapy, hyperthermic intraperitoneal chemotherapy for ovarian cancer, and medical education. Working on a national level to reduce the impact of gynecologic cancer.
Education & Training
UC San DiegoMAS, Advanced Clinical Research, 2014 - 2016
University of California (Irvine)Fellowship, Gynecologic Oncology, 2005 - 2009
University of Louisville School of MedicineResidency, Obstetrics and Gynecology, 2001 - 2005- University of Louisville School of MedicineClass of 2001
Certifications & Licensure
VA State Medical License 2019 - 2026
MD State Medical License 2024 - 2025
CA State Medical License 2005 - 2023- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Physicians of Excellence Orange County Medical Association, 2012-2018
- Southern California Super Doctors Rising Stars SuperDoctors.com, 2013-2015
Clinical Trials
- Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892).Sarah E Taylor, Sarah Behr, Kristine L Cooper, Haider Mahdi, Denise Fabian
Cancer Chemotherapy and Pharmacology. 2024-12-14 - Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3...Domenica Lorusso, Yang Xiang, Kosei Hasegawa, Giovanni Scambia, Manuel Leiva
Lancet. 2024-10-05 - Response to Alexandre Andre B A da Costa et al.Bradley J Monk, Robert L Coleman, Krishnansu S Tewari, Leslie M Randall, Bhavana Pothuri
Gynecologic Oncology. 2024-10-01
Lectures
- HIPEC: Standard of Care or Hype?ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Gynecologic Cancer Genetics Beyond2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- A phase I dose-escalation of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) carboplatin for the frontline treatment of advanced ovarian cancer.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Ancillary Tests in Gynecologic Pathology—What and WhyApril 20th, 2023- Spotlight on Ancillary Tests in Endometrial CancerMarch 18th, 2023
- Nykode Therapeutics Announces Collaboration with the GOG Foundation, Inc. To Conduct the VB-C-04 Trial in Advanced Cervical CancerFebruary 10th, 2023
- Join now to see all
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
